Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

This update is based on a press release statement from Invivyd, Inc. The company's stock has experienced significant volatility, with a 16.39% gain in the past week despite a 64.17% decline over six ...

Testing positive for COVID-19 is not exactly a positive experience ... Therefore, talk to a medical professional about whether you should get treatment and what kind. This should be a real ...

OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

It's indicated if you're 12 years of age or older, you weigh at least 88 pounds, and you test positive for coronavirus, and you're at high risk for hospitalization. What does that mean?

A part-time actor was sentenced to more than eight years in federal prison Monday for soliciting investors in companies that prosecutors said marketed a bogus cure and treatment for COVID-19.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

The “contrarian”-led task force that Premier Danielle Smith commissioned to review Alberta’s COVID-19 pandemic response has ...